UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece

International journal of hematology, 2017-02, Vol.105 (2), p.184-195

2017

Volltextzugriff (PDF)

Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank

Bioengineering (Basel), 2018-09, Vol.5 (4), p.77

2018

Volltextzugriff (PDF)

The Beliefs, Myths, and Reality Surrounding the Word Hema (Blood) from Homer to the Present

Anemia, 2010, Vol.2010, p.857657-6

2010

Volltextzugriff (PDF)

Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations

Virology journal, 2012-01, Vol.9 (1), p.1-1, Article 1

2012

Volltextzugriff (PDF)

Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma

International journal of hematology, 2014-06, Vol.99 (6), p.777-781

2014

Volltextzugriff (PDF)

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy

International journal of cancer, 2012-09, Vol.131 (6), p.1466-1471

2012

Volltextzugriff (PDF)

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

European journal of haematology, 2000-11, Vol.65 (5), p.331-336

2000

Volltextzugriff (PDF)

Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma

International journal of hematology, 2003-11, Vol.78 (4), p.344-348

2003

Volltextzugriff (PDF)

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

Blood, 2003-08, Vol.102 (3), p.1064-1069

2003

Volltextzugriff (PDF)

Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias

International journal of hematology, 2002, Vol.75 (1), p.40-44

2002

Volltextzugriff (PDF)

Thalassemia intermedia today: should patients regularly receive transfusions?

Transfusion (Philadelphia, Pa.), 2007-05, Vol.47 (5), p.792-800

2007

Volltextzugriff (PDF)

Severe thrombocytopenia related to trastuzumab infusion

Medical science monitor, 2011-07, Vol.17 (7), p.CS85-CS87

2011

Volltextzugriff (PDF)

Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria

Medical science monitor, 2003-07, Vol.9 (7), p.RA161-RA172

2003

Volltextzugriff (PDF)

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

The oncologist (Dayton, Ohio), 2016-03, Vol.21 (3), p.343-353

2016

Volltextzugriff (PDF)

Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?

Leukemia & lymphoma, 2017-07, Vol.58 (7), p.1743-1746

2017

Volltextzugriff (PDF)

Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients

International journal of hematology, 2002-05, Vol.75 (4), p.394-400

2002

Volltextzugriff (PDF)

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

International journal of cancer, 2012-02, Vol.130 (3), p.735-742

2012

Volltextzugriff (PDF)

A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty

British journal of haematology, 2010-11, Vol.151 (4), p.359-364

2010

Volltextzugriff (PDF)

Cardiac status in well-treated patients with thalassemia major

European journal of haematology, 2004-11, Vol.73 (5), p.359-366

2004

Volltextzugriff (PDF)

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal

Acta haematologica, 2019-01, Vol.142 (2), p.87-91

2019

Volltextzugriff (PDF)

Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation

European journal of haematology, 2018-02, Vol.100 (2), p.131-139

2018

Volltextzugriff (PDF)

Presence Of CD55- and/Or CD59-Deficient Erythrocytes In Patients With Rheumatic Diseases: An Immune-Mediated Phenomenon?

Blood, 2013-11, Vol.122 (21), p.3429-3429

2013

Volltextzugriff (PDF)

A Study of the Hereditary Hyperferritinemia Cataract Syndrome in Patients of Greek Origin

Blood, 2012-11, Vol.120 (21), p.3205-3205

2012

Volltextzugriff (PDF)

The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon

Medical science monitor, 2014-01, Vol.20, p.123-139

2014

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(57)
Science & Technology
(56)
Life Sciences & Biomedicine
(55)
Male
(41)
Female
(40)
Middle Aged
(36)
Aged
(31)
Adult
(30)
Hematology
(29)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Oncology
(19)
Aged, 80 And Over
(17)
Adolescent
(11)
Hematologic And Hematopoietic Diseases
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Multiple Myeloma
(9)
Treatment Outcome
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Paroxysmal Nocturnal Hemoglobinuria
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece

Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank

The Beliefs, Myths, and Reality Surrounding the Word Hema (Blood) from Homer to the Present

Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations

Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias

Thalassemia intermedia today: should patients regularly receive transfusions?

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B‐Cell Lymphoma: The Emerging Standard of Care

Severe thrombocytopenia related to trastuzumab infusion

Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?

Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty

Cardiac status in well-treated patients with thalassemia major

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal

Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation

Presence Of CD55- and/Or CD59-Deficient Erythrocytes In Patients With Rheumatic Diseases: An Immune-Mediated Phenomenon?

A Study of the Hereditary Hyperferritinemia Cataract Syndrome in Patients of Greek Origin

The presence of CD55- and/or CD59-deficient erythrocytic populations in patients with rheumatic diseases reflects an immune-mediated bone-marrow derived phenomenon

Suchergebnisse filtern